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Objective: To describe prevalence, prenatal diagnosis and outcome for fetuses and infants
with congenital hydrocephalus.
Methods: Data were taken from four European registries of congenital malformations
(EUROCAT). The registries included are based on multiple sources of information and
include information about livebirths, fetal deaths with GA  20 weeks and terminations of
pregnancy for fetal anomaly (TOPFA). All cases from the four registries diagnosed with
congenital hydrocephalus and born in the period 1996–2003 were included in the study.
Cases with hydrocephalus associated with neural tube defects were not included in the
study.
Results: Eighty-seven cases with congenital hydrocephalus were identified during the study
period giving an overall prevalence of 4.65 per 10,000 births. There were 41 livebirths (47%),
four fetal deaths (5%) and 42 TOPFA (48%). Nine percent of all cases were from a multiple
pregnancy. Additional non-cerebral major malformations were diagnosed in 38 cases (44%)
and karyotype anomalies in eight cases (9%). Median GA at TOPFA was 21 weeks. Among
livebirths 61% were diagnosed prenatally at a median GA of 31 weeks (range 17–40 weeks)
and median GA at birth was 37 weeks. Fourteen liveborn infants (34%) died within the first
year of life with the majority of deaths during the first week after birth.
Conclusion: Congenital hydrocephalus is a severe congenital malformation often associated
with other congenital anomalies. CH is often diagnosed prenatally, although sometimes
late in pregnancy. A high proportion of affected pregnancies result in termination for
severe fetal anomaly and there is a high mortality in livebirths.
ª 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights
reserved.fax þ45 7636 3474.
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ean Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
e u r o p e a n j o u rn a l o f p a e d i a t r i c n e u r o l o g y 1 4 ( 2 0 1 0 ) 1 5 0 – 1 5 5 1511. Introduction The four EUROCAT registries included in this study wereCongenital hydrocephalus is characterized by an abnormal
accumulation of cerebrospinal fluid (CSF) in the brain.1 In the
fetus and the infant the main clinical sign is enlargement of
the head although in some cases with cerebral ven-
triculomegaly the head circumference is within normal limits.
The CSF may be under pressure causing compression and
damage to the brain. The reason for the accumulation of the
CSF is an imbalance between production and absorption of the
CSF. The most common causes of congenital hydrocephalus
are obstruction of the cerebral aqueduct flow, Arnold Chiari
malformation or Dandy–Walker malformation.2
In fetuses and infants the diagnosis of hydrocephalus is
usually made following ultrasound scans. With the increasing
number and quality of prenatal ultrasound investigations
more cases are now diagnosed antenatally. The first prenatal
signs of hydrocephalus may be visible on ultrasound around
18–20 weeks of gestation, the ‘‘banana sign’’ though in some
cases the hydrocephalus is only visible later in gestation.
Parents face difficult decisions on whether to continue or
terminate the pregnancy when the diagnosis is made late in
the second trimester and information on prognosis related to
scan findings is lacking. For optimal counselling data on
pregnancy outcome and childhood outcome in liveborn
infants with congenital hydrocephalus are needed.
As congenital hydrocephalus is rare and because hydro-
cephalus also may be acquired after perinatal events
(tumours, cerebral bleeding, CNS infections) publications
give outcome data on these groups of infants together,3 or
include infants with spina bifida4 or cover a long time period
in order to have a reasonable number of cases.5 Further
published series only give data on liveborn infants referred
for surgery.4–6
The aim of this study is to give the prevalence of congenital
hydrocephalus in four European regions using population-
based data from European Surveillance of Congenital Anom-
alies (EUROCAT) and describe prenatal diagnosis, outcome of
pregnancy and mortality for the liveborn infants.2. Materials and methods
EUROCAT registries are population-based and the geographi-
cally defined populations and methods of case ascertainment
of EUROCAT are described elsewhere (http://www.eurocat.
ulster.ac.uk/memberreg). The registries are based on
multiple sources of information such as hospital records, birth
and death certificates and post mortem examinations, and
include information about livebirths (LB), fetal deaths (FD)
with gestational age (GA)  20 weeks and terminations of
pregnancy (TOPFA) after prenatal diagnosis of malformations.
All structural malformations, syndromes and chromosomal
anomalies are included in the database. Minor malformations
are excluded according to an exclusion list. Malformations are
coded according to ICD9/BPA or ICD10/BPA. The EUROCAT
definition of hydrocephalus is: dilatation of ventricular
system, not due to primary atrophy of the brain, with or
without enlargement of the skull.Vaud (Switzerland), Oxford (UK), Funen County (Denmark)
and Zagreb (Croatia). All cases born between 1996 and 2003
with a code for congenital hydrocephalus (ICD9, 7423
excluding hydranencephaly; ICD10, Q03) from the four regis-
tries were identified in the central EUROCAT database. Cases
with associated neural tube defects were excluded from the
study. Also cases with Dandy-Walker without hydrocephalus
were excluded manually as the codes 74231 and Q031 code for
Dandy-Walker both with and without hydrocephalus. All
cases were checked to exclude cases with primary atrophy of
the brain.
Available data in the database included sex, outcome of
birth (liveborn, stillborn, termination of pregnancy), time
of diagnosis, GA at discovery if prenatally diagnosed, age of
mother and associated malformations. An additional ques-
tionnaire was filled in for each case with data on mode of
delivery, induction of birth and indication, head circumfer-
ence, description of diagnostic tests performed and, for live-
born infants, surgical procedures and outcome at 1 or 3 years
of age.
The total number of births covered in the four regions
1996–2003 was 186,922.
Normal values for head circumference for comparison
with study cases were taken from a recent Norwegian
publication,7 where the results were very similar to a British
study published in 1994.8 Head circumference values from
the study came from direct measurements at birth or at
termination, while the data for comparison is based on
ultrasound studies.3. Results
Fig. 1 shows the total number of cases pre- and postnatally
diagnosed with outcome of pregnancy and survival.3.1. Prevalence and birth outcome
Eighty-seven cases with congenital hydrocephalus were
identified in the four EUROCAT registries during the study
period giving an overall prevalence of 4.65 per 10,000 births (CI
3.77–5.74). Data on cases and prevalence by registry is pre-
sented in Table 1. Prevalence between regions differed
significantly ( p < 0.05). There were 41 livebirths (47%), four
fetal deaths (5%) and 42 TOPFA (48%).
Median birthweight and GA for liveborn infants was low
(median birthweight 2600 g and median GA 37 weeks). Nine
percent of all cases (8/87) were from a multiple pregnancy.
Seventy (80%) of the 87 cases were diagnosed prenatally. Of
the 41 liveborn infants 61% were diagnosed prenatally. For
those cases resulting in TOPFA median GA at prenatal diag-
nosis was 19 weeks; median gestation at prenatal diagnosis
for livebirths was 31 weeks (Table 2).
For TOPFA cases median time interval from diagnosis to
termination was 2 weeks. For prenatally diagnosed livebirths
median GA at birth was 36 weeks compared to a median GA at
prenatal diagnosis at 31 weeks.
87 cases with
congenital
hydrocephalus
48 cases with
isolated
hydrocephalus
39 cases with non-cerebral
malformation and/or
karyotype anomalise
37 cases diagnosed
prenatally
11 cases diagnosed
postnatally
33 cases diagnosed
prenatally
6 cases diagnosed
postnatally
22 terminations of
pregnancy
2 fetal deaths
13 livebirths
11 livebirths 20 terminations of
pregnancy
1 fetal death
12 livebirths
1 fetal deaths
5 livebirths
8 survivors at 1 week
5 died
11 survivors at 1
week
7 survivors at 1 week
4 died
1 unknown
4 survivors at 1 week
1died
Fig. 1 – Flowchart for outcome of 87 cases with congenital hydrocephalus.
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Non-cerebral major malformations were present in 38 cases
(44% of total) with the same proportion among livebirths, fetal
deaths and TOPFA. Diagnosed syndromes and associated non-
cerebral malformations are listed in Tables 3 and 4. The most
frequent non-cerebral malformations were facial clefts,
congenital heart disease and polycystic kidneys. Two cases
were diagnosed with Fryns syndrome and two with Meckel–
Gruber syndrome. In seven of these 38 cases there was an
abnormal karyotype and a further one case had an abnormal
karyotype with hydrocephalus as the only major malforma-
tion. Three cases had triploidy and the remaining five cases
had different karyotype anomalies.Table 1 – Data on 87 cases congenital hydrocephalus by regist
Years
included
Total
births
Number of
cases
Preva
Vaud 1996–2003 58755 35
Oxford 1996–2002 41795 20
Funen
County
1996–2003 44307 23
Zagreb 1996–2002 42065 9
Total 186922 87
a Confidence interval.3.3. Head circumference and mode of delivery
Head circumference measured at birth, termination or at post
mortem examination is presented in Fig. 2 and compared to
published normal values.7 It is evident that around half of all
cases have a head circumference above normal limits at the
time of birth or termination.
For livebirths there were only nine cases with a spon-
taneous birth and seven of these had a postnatal diagnosis
of hydrocephalus. In 21 cases the birth was induced and
for 11 cases induction of birth was not known. Mode of
delivery was vaginal for 11 cases, planned cesarean
section in 15 and acute cesarean section in eight cases
(seven unknown).ry.
lence per 10,000 births
(CI)a
Livebirths
(% of total)
Fetal
deaths
(% of total)
TOPFA
(% of total)
5.96 (4.28–8.30) 14 (40) 0 21 (60)
4.79 (3.09–7.41) 10 (50) 1 (4) 9 (45)
5.19 (3.45–7.81) 14 (61) 1 (4) 8 (35)
2.14 (1.11–4.11) 3 (33) 2 (22) 4 (44)
4.65 (3.77–5.74) 41 (47) 4 (5) 42 (48)
Table 2 – Characteristics of 87 cases with congenital hydrocephalus.
Livebirths (N[ 41) Fetal deaths (N[ 4) TOPFA (N[ 42)
Birthweight, median (range) (g) 2600 (633–4678) 1300 (1080–3700) 330 (25–1650)
GA, median (range) (weeks) 37 (28–41) 29 (24–33) 21 (14–31)
Boys/girls 21/18a 3/1 23/17a
Maternal age,
median (range) (years)
30 (19–40) 34 (33–35) 30 (18–41)
Multiple pregnancy 3 0 5
Prenatal diagnosis (%) 25 (61) 3 (75) 42 (100)
GA at prenatal
diagnosis, median
(range) (weeks)
31 (17–40) 26 (20–32) 19 (13–30)
Non-cerebral malformations (%) 17 (41) 2 (50) 19 (45)
Karyotype performed (%) 16 (39) 2 (50) 29 (69)
Karyotype abnormal 0 0 8b
a Two unknown.
b Seven of these with non-cerebral malformations.
Table 4 – Non-cerebralmajormalformations diagnosed in
38 cases with congenital hydrocephalus, including
malformations diagnosed in cases with syndromes and
karyotype anomalies.
Associated anomalies LB FD TOPFA
Eye 2
Other malformations of face 2
Cleft lip and palate 1 2
Cleft palate 1 4
VSD or ASD 3 2
Hypoplastic left heart 1
Pulmonary valve stenosis 1
Ectopia cordis 1
Unspecified cardiac 1
Coarctation of aorta 1 1
Patent ductus 1
Lung cyst 1
Diaphragmatic hernia 2
Abdominal cyst 1
e u r o p e a n j o u rn a l o f p a e d i a t r i c n e u r o l o g y 1 4 ( 2 0 1 0 ) 1 5 0 – 1 5 5 1533.4. Survival and surgery
Thirty of 41 infants survived the first week of life. Ten infants
died within the first week (1 week survival was unknown for
one case), four infants died later in the first year of life giving
a total first year mortality of 38% (14/37 as 1 year survival was
unknown for four cases). Five of 24 infants (21%) without non-
cerebral major malformations died within the first week
compared to five of 16 infants (31%, one unknown) with non-
cerebral major malformations ( p ¼ 0.46).
Data on surgery was only available from Switzerland and
Denmark (28 livebirths). Surgery was performed on 16 infants
of which two later died. Eight of the 16 children with surgery
had one or more repeated operations performed within the
first 3 years, mainly for shunt dysfunction. Surgery was not
performed on 11 cases, three of whom were alive at 1 year. Of
the remaining eight cases without surgery, seven died on the
day of birth. Data on surgery was unavailable for one baby
with multiple malformations who died 6 days after birth.
3.5. Follow-up of survivors
Follow-up of survivors was only available in Denmark. At
3 years of age four of the nine surviving children were found to
have normal development for age. The five children that were
not normal had mental retardation and/or cerebral palsy.
Seven of the nine children were walking alone and a further
one walking with aids. Overall of 23 cases with CH from
Denmark, nine were alive at 3 years of age and four of these
were normal for age.Table 3 – Syndromes diagnosed in nine cases with
congenital hydrocephalus.
Syndromes LB FD TOPFA
Fryns syndrome 2
Meckel–Gruber syndrome 1 1
Noonan syndrome 1
Crouzon syndrome 1
Thanathoric dwarfism 1
Undiagnosed syndrome 24. Discussion
Our study found a prevalence of CH at 4.65 per 10,000 births.
Prevalence of CH (as defined in this study) has previously been
reported to be 3.7 per 10,000 births in a Northern Region in the
UK 1985–19969 and 8.1 per 10,000 births in Strasbourg, France
1979– 1987.10 In the French study a large proportion of cases
(29%) were diagnosed in infancy (after 1 week). As theAnal atresia 1
Polycystic kidneys 2 4
Unilateral renal agenesis 1
Hydronephrosis bilateral 1
Posterior urethral valves 1
Horseshoe kidney 1
Omphalocele 2
Club feet 2
Syndactyly 2
Limb reduction defect 2
Polydactyly 1
Limb–body wall complex 1
Multiple malformations, unspecified 2
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Fig. 2 – Head circumference in congenital hydrocephalus
cases compared to 5th and 95th percentile according to
reference (ref: Johnsen7).
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the ventricles, prevalence may differ between studies. In our
study difference in prevalence between regions was statisti-
cally significant, from 2.14 to 5.69 per 10,000 cases. All four
registries are relatively small with good ascertainment of
malformed cases.
The British study9 showed a significant increase in total
prevalence over time due to increased prenatal detection
while the livebirth prevalence remained stable. Fetal deaths
that previously remained undiagnosed may have been diag-
nosed prenatally and terminated. Livebirth prevalence in the
French study (1979–1987) was 4.8 per 10,000 births, in the
British study (1996–2003) 2.5 per 10,000 births compared to 2.2
per 10,000 births in our study (1996–2003). Terminations of
pregnancy have approximately halved the livebirth preva-
lence of CH. Whether those prenatally diagnosed were more
severe cannot easily be assessed.
We found a high proportion of associated malformations
and karyotype anomalies (46%) among our CH cases. This high
proportion of associated anomalies is comparable to what is
found for omphalocele, where about half of the cases have
associated anomalies.11 Other studies of CH have also shown
this high proportion of associated malformations and karyo-
type anomalies.9,10 This emphasizes the importance of looking
for other malformations after a prenatal or postnatal diagnosis
of CH. Studies of major malformations of other organ systems
have shown the impact of associated malformations and
karyotype anomalies on birth outcome and survival.12–14 In our
study of a severe cerebral malformation the distribution of
associated malformations was almost the same for those cases
resulting in TOPFA and livebirths (45 and 41%) and there was no
significant difference in 1 week mortality for livebirths with or
without associated non-cerebral malformations. All cases
with a karyotype anomaly were terminated.
Nine percent of our cases were from a multiple pregnancy,
a proportion that is much higher than the normal twin rate of
around 2% of all newborns. It has been described previously
that hydrocephalus is significantly more frequent in twins15but the importance of our data is that it includes only CH
whether diagnosed pre- or postnatally and thus excludes
those hydrocephalus cases resulting from prematurity-
related perinatal events. This finding is important in relation
to the increasing number of multiple pregnancies in Europe
due to assisted conceptions. Following prenatal diagnosis of
a severe malformation in a fetus from a multiple pregnancy
parents may request selective TOPFA for the affected fetus –
a difficult ethical problem.
Eighty percent of all cases in our study were diagnosed
prenatally and for livebirths the prenatal detection rate was
61%. There was a clear relation between GA at diagnosis and
outcome of pregnancy as median GA for prenatal diagnosis for
TOPFA cases was 19 weeks compared to 31 weeks for live-
births. Only seven of 25 liveborn cases were prenatally diag-
nosed before 28 weeks. This suggests that the timing of
prenatal diagnosis may be the main criterion for deciding
whether to terminate the pregnancy. Approximately half of
our cases with CH had a head circumference within normal
limits for GA suggesting that prenatal diagnosis by ultrasound
is based on visualizing the dilatation of the ventricles and not
on the size of the fetal head. We are not aware of other studies
showing head circumference for CH cases at TOPFA or birth.
In our study cases were included if the hydrocephalus fitted
with the EUROCAT definition: dilatation of ventricular system,
not due to primary atrophy of the brain, with or without
enlargement of the skull. None of the cases had borderline
cerebral ventriculomegaly (width of ventricle <15 mm) noted
on scan prenatally. Further we reviewed the cases from each
registry reported with ‘‘ventriculomegaly’’ and we found no
cases among them that at birth fulfilled our definition of
hydrocephalus. Although the neurodevelopmental outlook for
isolated borderline ventriculomegaly (normal karyotype, no
associated malformations) is good if the measurement is
<12 mm, it is less favourable when the ventricles measure
>12 mm.16
Our study showed a poor prognosis for fetuses with CH.
Only 47% of all cases were livebirths and of these 25% died
within the first week after birth and at 1 year of age mortality
was at least 38% (four infants with unknown infant survival).
We are not aware of other studies on CH and survival for direct
comparison with our data. Studies on disabilities in survivors
with infant hydrocephalus of different etiologies have shown
that more than half of all children have developmental or
neurological problems.4–6 The survival in our study is
comparable to the survival published more than 20 years ago:
one study on prenatally diagnosed CH including neural tube
defects17 and one study on CH overt at birth.18 The literature
further states that there is little or no correlation between
the size of the ventricles and subsequent handicap.19
Further follow-up of the development and needs of chil-
dren with hydrocephalus surviving infancy is needed. Data
from European registries on cerebral palsy (SCPE) shows that
CH is the second most frequent congenital malformation
among children with CP.20 Also investment in research on
surgery for hydrocephalus to improve outcomes is
recommended.
In conclusion CH is a severe congenital malformation,
often diagnosed prenatally, although sometimes rather late in
pregnancy and with a high proportion of associated
e u r o p e a n j o u rn a l o f p a e d i a t r i c n e u r o l o g y 1 4 ( 2 0 1 0 ) 1 5 0 – 1 5 5 155anomalies. Outcome is poor with a high proportion of preg-
nancies terminated for severe fetal anomaly and a high
mortality in livebirths.
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